論文

国際誌
2020年10月15日

Bone Marrow Endothelial Cells Take Up Blood-Borne Immune Complexes via Fcγ Receptor IIb2 in an Erythropoietin-Dependent Manner.

Journal of immunology (Baltimore, Md. : 1950)
  • Takeshi Ito
  • ,
  • Kohei Kometani
  • ,
  • Nagahiro Minato
  • ,
  • Yoko Hamazaki

205
8
開始ページ
2008
終了ページ
2015
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.4049/jimmunol.1901101

Immune complexes (ICs) in blood are efficiently removed mainly by liver reticuloendothelial systems consisting of sinusoidal endothelial cells and Kupffer cells expressing FcγR. The bone marrow (BM) also has sinusoidal vasculatures, and sinusoidal BM endothelial cells (BMECs) bear unique function, including hematopoietic niches and traffic regulation of hematopoietic cells. In this study, we found that sinusoidal BMECs express FcγRIIb2, which is markedly increased in anemic conditions or by the administration of erythropoietin (Epo) in healthy mice. BMECs expressed Epo receptor (EpoR), and the Epo-induced increase in FcγRIIb2 expression was abolished in Epor-/- ::HG1-Epor transgenic mice, which lack EpoR in BMECs except for BM erythroblasts, suggesting the effect was directly mediated via EpoR on BMECs. Further, although BMECs hardly captured i.v.-injected soluble ICs in healthy mice, Epo administration induced a remarkable increase in the uptake of ICs in a FcγRIIb-dependent manner. Enhancement of the IC incorporation capacity by Epo was also observed in cultured BMECs in vitro, suggesting the direct effect of Epo on BMECs. Moreover, we found that i.v.-injected ICs in Epo-treated mice were more rapidly removed from the circulation than in PBS-treated mice. These results reveal a novel function of BMECs to efficiently remove circulating blood-borne ICs in an FcγRIIb2-mediated manner.

リンク情報
DOI
https://doi.org/10.4049/jimmunol.1901101
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/32907997
ID情報
  • DOI : 10.4049/jimmunol.1901101
  • PubMed ID : 32907997

エクスポート
BibTeX RIS